



Healthcare | Small Cap
Take Solutions Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strengths in solvency and growth, particularly in earnings per share. However, it struggles with liquidity, efficiency, coverage, financial metrics, and profitability. While the company's earnings per share growth and equity-related solvency metrics are positive, its poor liquidity and profitability raise concerns. The company's ability to meet its short-term obligations and generate profits is questionable. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further affect the company's financial stability. The company needs to address these weaknesses to ensure long-term sustainability and growth.
Take Solutions Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strengths in solvency and growth, particularly in earnings per share. However, it struggles with liquidity, efficiency, coverage, financial metrics, and profitability. While the company's earnings per share growth and equity-related solvency metrics are positive, its poor liquidity and profitability raise concerns. The company's ability to meet its short-term obligations and generate profits is questionable. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further affect the company's financial stability. The company needs to address these weaknesses to ensure long-term sustainability and growth.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
111.39
Industry Median
25.40
Small Cap Median
23.33
P/E RATIO
27.47
P/B RATIO
9.55
Industry Median
9.33
Small Cap Median
9.12
P/S RATIO
5.50
Industry Median
4.72
Small Cap Median
3.95
Others
PEG RATIO
0.00
EV/EBITDA RATIO
26.95
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹20.05 as on Jul 16, 2026.
The company exhibits mixed growth performance. While earnings per share (EPS) growth is strong, revenue, operating profit, asset, and net income growth rates are low. This suggests that while the company is improving its profitability on a per-share basis, it is not experiencing overall growth in key areas such as revenue and assets. The healthcare sector's growth is influenced by factors such as demographics, healthcare spending, and technological advancements. The company needs to focus on driving revenue and asset growth to ensure long-term sustainability.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue Growth Rate | -15.37 | -71.15 | -97.88 | -100 |
| Operating Profit Growth Rate | 109.59 | -371.43 | -5.26 | 65 |
| Earnings Per Share (EPS) Growth | -73.04 | 87.18 | -19.32 | 131.27 |
| Asset Growth Rate | -33.02 | -81.68 | -60.71 | -59.09 |
| Net Income Growth Rate | -73.78 | 87.21 | -20 | 130.83 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Yash Optics & Lens Ltd | 6.75 | 29.97 | Neutral | 14.74 | 3.65 | 9.05 |
| 2 | Take Solutions Ltd | 3.89 | 27.47 | Neutral | -2.00 | 0.18 | 11.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Take Solutions Ltd. historically provided IT solutions and services primarily for the Life Sciences and Supply Chain Management sectors. Following a major divestment of its core Life Sciences services business in 2021, the company's active operations are now significantly scaled down, focusing primarily on residual IT services and managing its remaining assets.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Take Solutions Ltd's P/E ratio (TTM) is 111.39, compared to the industry median of 25.40 and large cap median of 23.33.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Take Solutions Ltd's P/B ratio is 9.55, compared to the industry median of 9.33 and large cap median of 9.12.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Take Solutions Ltd's P/S ratio is 5.50, compared to the industry median of 4.72 and large cap median of 3.95.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Take Solutions Ltd's PEG ratio is N/A.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Take Solutions Ltd's EV/EBITDA ratio is 26.95.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Take Solutions Ltd's ROE is 35.48%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Take Solutions Ltd's ROA is -5.56%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Take Solutions Ltd's ROCE is 19%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Take Solutions Ltd's operating margin is -3.70%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Take Solutions Ltd's net margin is 20.37%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Take Solutions Ltd's current ratio is 7.20.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Take Solutions Ltd's debt-to-equity ratio is 0.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Take Solutions Ltd's interest coverage ratio is 19.50.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Take Solutions Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Take Solutions Ltd's EPS is -71.15.
(Source line: "Ratios as of 22 Nov 2026, based on last traded price of ₹20.05. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1999 (as TAKE Solutions.com India Limited)
Headquarters: Chennai, Tamil Nadu
Core Offerings: Historically: Life Sciences services (pharmaceutical, clinical, regulatory), Supply Chain Management solutions, IT consulting. Current active operations are largely residual.
Stock Listing: NSE (TAKE), BSE (532890)
Promoter: H.R. Srinivasan
Founded in 1999 as TAKE Solutions.com India Limited, the company was renamed TAKE Solutions Limited in 2004. It expanded its focus on IT solutions for Life Sciences and Supply Chain Management globally. A pivotal moment occurred in 2021 when the company divested its entire Life Sciences services business (TAKE Solutions Inc. and its subsidiaries), its primary revenue generator, to Navis Capital Partners. Post-divestment, the company's operations have been significantly limited, with a focus on managing residual assets and exploring future strategies.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Core Operations | 100% | Operating Profit |
Divestment of Core Business: In 2021, the company divested its entire Life Sciences services business (TAKE Solutions Inc. and its subsidiaries), which was its primary revenue generator, to Navis Capital Partners for significant consideration.
Residual Operations: Post-divestment, the company's active business operations are minimal, primarily consisting of residual IT services and managing its remaining assets and investments.
Strategic Re-evaluation: The company is in a phase of strategic re-evaluation, with limited ongoing operational activities and no significant revenue-generating business segments currently active.
Mr. H.R. Srinivasan - Vice Chairman, Managing Director & CEO. A co-founder, he has played a crucial role in shaping the company's vision and strategy, especially in its former Life Sciences domain.
No major operating subsidiaries reported post-divestment, as key revenue-generating entities were part of the 2021 divestment. Some remaining entities are non-operational or undergoing liquidation.
Major divestment of Life Sciences Services business in 2021 to Navis Capital Partners. Bonus Issue in 2018 (1:1).
The Take Solutions Ltd share price today is ₹20.05 on NSE (TAKE), as of 22 Nov 2026.
As of 22 Nov 2026, Take Solutions Ltd share price is ₹20.05, with previous close ₹20.05. Today's range is ₹20.05 to ₹20.05. The 52-week range is ₹9.88 to ₹50.14.
As of today, Take Solutions Ltd's market cap is ₹296.74 crore (Small Cap).
Take Solutions Ltd's current P/E ratio is 111.39, compared to the PHARMACEUTICALS & BIOTECHNOLOGY sector average of 36.50.
Take Solutions Ltd's current P/B ratio is 9.55.
Take Solutions Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Take Solutions Ltd's EPS (TTM) is ₹-71.15.
Take Solutions Ltd. historically provided IT solutions and services primarily for the Life Sciences and Supply Chain Management sectors. Following a major divestment of its core Life Sciences services business in 2021, the company's active operations are now significantly scaled down, focusing primarily on residual IT services and managing its remaining assets.
Take Solutions Ltd is promoted by H.R. Srinivasan, holding 0% as of 22 Nov 2026.
Take Solutions Ltd is listed on NSE (TAKE) and BSE (532890). Its next quarterly results are expected on August 2024 (expected Q1 FY25).